Cargando…
Novel Antischizophrenia Treatments
This volume tries to put current therapy - achievements, shortcomings, remaining medical needs - and emerging new targets into the context of increasing knowledge regarding the genetic and neurodevelopmental contributions to the pathophysiology of schizophrenia. Some of the chapters also deal with r...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2012.
|
| Edición: | 1st ed. 2012. |
| Colección: | Handbook of Experimental Pharmacology,
213 |
| Temas: | |
| Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- Preface
- Clinical instruments to evaluate and guide treatment in schizophrenia
- Cognitive deficits in schizophrenia- Muscarinic mechanisms in psychotic disorders
- Nicotinic mechanisms in psychotic disorders
- GABAergic circuits in schizophrenia: targets for new treatments in schizophrenia
- Inhibitors of glycine transport as potential new treatments in schizophrenia
- The role of glutamate in schizophrenia
- Metabotropic glutamate receptors as targets for new treatments in schizophrenia
- 5-HT2C agonism as a principle for new treatments in schizophrenia.- The role of dopamine D3 receptors for antipsychotic activity and cognitive functions
- Phosphodiesterase inhibitors as potential new treatments in schizophrenia
- Disease modifying approaches to schizophrenia
- A novel therapeutic strategy: medication-enhancement of cognitive therapies in schizophrenia
- Transgenic animals reflecting aspects of schizophrenia
- Behavioral animal models of pro-cognitive treatments for schizophrenia. .